Novabridge Biosciences ADR
(NBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 06-2022 | 12-2021 | 06-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 480,016 | 554,023 | 552,935 | 673,738 | 729,315 |
| Marketable Securities | 34,134 | 31,529 | 118,188 | 65,413 | 4,832 |
| Receivables | 0 | 76 | 5,191 | N/A | 20,000 |
| Inventories | 0 | N/A | 4,274 | N/A | 0 |
| Other current assets | 11,639 | 58,537 | 69,768 | 68,661 | 64,806 |
| TOTAL | $525,789 | $644,165 | $750,356 | $807,812 | $818,953 |
| Non-Current Assets | |||||
| PPE Net | 17,750 | N/A | 14,104 | N/A | 8,608 |
| Investments And Advances | 4,473 | 32,496 | 55,253 | 89,525 | 101,890 |
| Other Non-Current Assets | 42,390 | 44,376 | 48,468 | 44,724 | 43,683 |
| TOTAL | $64,613 | $76,872 | $117,825 | $134,249 | $154,181 |
| Total Assets | $590,625 | $745,223 | $878,949 | $952,205 | $970,697 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,748 | N/A | 0 | N/A | 0 |
| Other current liabilities | 103,701 | 81,736 | 93,107 | 83,747 | 87,060 |
| TOTAL | $109,923 | $88,085 | $97,920 | $85,280 | $88,295 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 54,156 | 48,401 | 52,700 | 16,487 | 19,154 |
| TOTAL | $54,156 | $48,401 | $52,700 | $16,487 | $19,154 |
| Total Liabilities | $168,729 | $145,638 | $163,454 | $106,606 | $108,298 |
| Shareholders' Equity | |||||
| Common Shares | 19 | 20 | 20 | 19 | 17 |
| Retained earnings | -994,918 | -806,451 | -683,368 | -480,094 | -310,083 |
| Other shareholders' equity | 30,916 | 7,025 | -29,267 | -19,262 | -7,784 |
| TOTAL | $421,896 | $599,585 | $715,495 | $845,599 | $862,399 |
| Total Liabilities And Equity | $590,625 | $745,223 | $878,949 | $952,205 | $970,697 |